References
- Ang C.W., Jacobs B.C., Laman J.D.: The Guillain-Barre’ syndrome: a true case ofmolecular mimicry. Trends Immunol. 25, 6–66 (2004)
- Ashgar S.S., Oldfield N.J., Wooldridge K.G., Jones M.A., Irving G.J., Turner D.P., Ala’Aldeen D.A.: CapA, an autotransporter protein of Campylobacter jejuni mediates association with human epithelial cells and colonization of the chicken gut. J. Bacteriol. 189, 1856–1865 (2007)
- Awad W.A., Hess C., Hess M.: Enteric pathogens and their toxin-induced disruption of the intestinal barrier through alteration of tight junctions in chickens. Toxins, 9(2017)
- Avrain L., Vernozy-Rozand C., Kempf I.: Evidence for natural horizontal transfer of tetO gene between Campylobacter jejunistrains in chickens. J. Appl. Microbiol. 97, 134–140 (2004)
- Backert S., Boehm M., Wessler S., Tegtmeyer N i wsp.: Transmigration route of Campylobacter jejuni across polarized intestinal epithelia cells: paracellular, transcellular or both? Cell Commun. Signal. 11, 72–87 (2013)
- Bilińka M., Koszewicz M.: Zespół Millera-Fishera z dominującymi zaburzeniami połykania i mowy. Adv. Clin. Exp. Med. 13, 515–519 (2004)
- Bolinger H., Kathariou S.: The Current state of macrolide resistance in Campylobacter spp.: Trends and impacts of resistance mechanisms. Appl. Environ. Microbiol. 83, e0046-17 (2017)
- Bronnec V., Turo H., Bouju A., Cruveiller S., Rodrigues R., Demnerova K., Tresse O., Haddad N., Zagorec M.: Adhesion, biofilm formation, and genomic features of Campylobacter jejuniBf, an atypical strain able to grow under aerobic conditions. Front. Microbbiol. 7, 1002 (2016)
- Bronowski C., James C.E., Winstanley C.: Role of environmental survival in transmission of Campylobacter jejuni. FEMS Microbiol. Lett. 356,8–19 (2014)
- Caldwell D.B., Wang Y., Lin J.: Development, stability, and molecular mechanisms of macrolide resistance in Campylobacter jejuni. Antimicrob. Agents Chemother. 52, 3947–3954 (2008)
- Ó Cróinín T., Backert S.: Host epithelial cell invasion by Campylobacter jejuni: trigger or zipper mechanism? Front. Cell. Infect. Microbiol. 2, 25 (2012)
- Chandrashekhar K., Kassem I. I., Rajashekara G.: Campylobacter jejuni transducer like proteins: Chemotaxis and beyond. Gut Microbes, 8, 323–334 (2017)
- Chopra I.: Mode of action of the tetracyclines and the nature of bacterial resistance to them, in The Tetracyclines (w) Handbook of Experimental. red.: Hlavka J.J., Boothe J.H., Springer, Berlin, Germany, 1985, s. 317392.
- Coker O., Akitoye I., Raphael D., Thomas N., Bolaji A., Kehinde O., Obi L.C.: Human campylobacteriosis in developing countries. Emerg. Infect. Dis. 8, 237–243 (2002)
- Day C.J., Semchenko E.A., Korolik V.: Glycoconjugates play a key role in Campylobacter jejuni infection between host and pathogen. Front. Cell. Infect. 2, 1–8 (2012)
- Dimachkie M.M., Barohn R.J.: Guillain-Barré syndrome and variants. Neurol. Clin. 31, 491–510 (2013)
- Engberg J., Aarestrup F. M., Taylor D.E., Gerner-Smidt P., Nachamkin I.: Quinolone and macrolide resistance in Campylobacter jejuni and C. coli: Resistance mechanisms and trends in human isolates. Emerg. Infect. Dis. 7, 24–34 (2001)
- Epps S.V.R., Harvey R.B., Hume M.E., Phillips T.D., Anderson R.C., Nisbet D.J.: Foodborne Campylobacter: Infections, Metabolism, Pathogenesis and Reservoirs. Int. J. Environ. Res. Public Health,10, 6292–6304 (2013)
- Esson D., Grant A.J. i wsp.: Identyfication and initial characterisation of a protein involved in Campylobacter jejuni cell shape. Mirobial Pathogenesis, 104, 202–211 (2017)
- Faber E., Gripp E., Maurischat S, Kaspers B., Tedin K., Menz S., Zuraw A., Kershaw O., Yang I., Rautenschlein S., Josenhansa C.: Novel immunomodulatory Flagellin-Like Protein FlaC in Campy lobacter jejuni and other Campylobacterales. mSphere. 1, 1–24 (2015)
- Flanagan R.C., Neal-McKinney J.M., Dhillon A.S., Miller W.G., Konkel M.E.: Examination of Campylobacter jejuni putative adhesins leads to the identification of a new protein, designated FlpA, required for chicken colonization. Infect. Immun. 77, 2399–2407 (2009)
- Friis C., Wassenaar T.M., Javed M.A., Snipen L., Lagesen K., Hallin P.F., Newell D.G., Toszeghy M., Ridley A., Manning G., Ussery D.W.: Genomic characterization of Campylobacter jejunistrain M. PLoS One, 5, e12253 (2010)
- Gibreel A. and Taylor D.E.: Macrolide resistance in Campylobacter jejuni and Campylobacter coli. J. Antimic. Chemother. 58, 243–255 (2006)
- Guerry P., Monterino M.A. i wsp.: Campylobacter polysaccharide capsules: virulence and vaccines. Front. Cell. Infect. Microbiol. 2, 1–11 (2012)
- Han a Zifeng, Willer T., Li L., Pielsticker C., Rychlik I., Velge P., Kaspers B., Rautenschleina S.: Influence of the gut Microbiota composition on Campylobacter jejuni colonization in chickens. Infect. Immun. 85, 11e00380 (2017)
- Hermans D., van Deun K., Martel A., van Immerseel F., Messens W., Heyndrickx M., Haesebrouck F., Pasmans F.: Colonization factors of Campylobacter jejuni in the chicken gut. Vet. Res. 42, 82 (2011)
- Hofreuter D.: Defining the metabolic requirements for the growth and colonization capacity of Campylobacter jejuni. Front. Cell. Infect Microbiol. 4, 137 (2014)
- Horrocks S.M., Anderson R.C., Nisbet D.J., Ricke S.C.: Incidence and ecology of Campylobacter jejuni and coli in animals. Anaerobe,15, 18–25 (2009)
- Ikeda N., Karlyshev A.V.: Putative mechanisms and biological role of coccoid form formation in Campylobacter jejuni. Eur. J. Microbiol. Immunol. 1, 41–49 (2012)
- Ilyas A.A., Mithen F.A., Chen Z.W., Cook S.D.: Search for antibodies to neutral glycolipids in sera of patients with Guillain-Barré syndrome. J. Neurol. Sci. 102, 67–75 (1992)
- Ilyas A.A., Mithen F.A., Dalakas M.C., Chen Z.W., Cook S.D.: Antibodies to acidic glycolipids in Guillain-Barre syndrome and chronic inflammatory demyelinating polyneuropathy. J. Neurol. Sci. 107, 111–121 (1992)
- Indikova I., Humphrey T.J., Hilbert F.: Survival with a helping hand: Campylobacter and microbiota. Front. Microbiol. 6, 1266 (2015)
- Iovine N. M.: Resistance mechanisms in Campylobacter jejuni. Virulence,4, 230–240 (2013)
- Jannsen R., Krogfelt K.A, Cawthraw S.A., van pelt W., Wagenaar J.A., Owen R.J.: Host-pathogen interactions in Campylobacter infections: the host perspective. Clin.Microbiol. Rev. 21, 505–518 (2008)
- John D.A., Williams L.K., Kanamarlapudi V., Humphrey T.J., Wilkinson T.S.: The bacterial species. Campylobacter jejuniinduce diverse innate immune responses in human and avian intestinal epithelial cells. Front. Microbiol. 8, 1840 (2017)
- Johnson T.J., Shank J.M., Johnson J.G.: Current and potential treatments for reducing Campylobacter colonization in animal hosts and disease in humans. Front. Microbiol. 8, 1–14 (2017)
- Kaakoush N.O., Castańo-Rodríguez N., Mitchell H.M., Mana S.M.: Global epidemiology of Campylobacter infection. Clin. Microbiol. Rev. 28, 687–720 (2015)
- Kaakoush N.O., Mitchell H. M.: Campylobacter concisus – new player in intestinal disease. Front.Cell. Infect. Microiol. 2, 1–12 (2012)
- Kimoto. K., Koga M., Hirata K., Takahashi M., Li J., Gilbert M., Yuki N.: Relationship of bacterial strains to clinical syndromes of Campylobacter– associated neuropathies. Neurology. 67, 1837–1843 (2006)
- Kobierecka P.A., Jagusztyn-Krynicka E.K. i wsp.: In vitro characteristics of Lactobacillus spp. strains isolated from the chicken digestive tract and their role in the inhibition of Campylobactercolonization. Microbiol. Open. 6, 1–15 (2017)
- Koga M., Takahashi M., Masuda M., Hirata K., Yuki N.: Campylobacter gene polymorphism as a determinant of clinical features of Guillain-Barre syndrome. Neurology, 65, 1376–1381 (2005)
- Koga M., Yuki N., Takahashi M., Saito K., Hirata K.: Close association of IgA anti-gangloside antibodies with antecedent Campylobacter jejuni infection in Guillain-Barre and Fisher’s syndromes. J. Neuroimmunol. 81, 138–143 (1998)
- Kurtkiewicz A.: Kampylobakteriozy u ludzi i zwierząt. Życie Weterynaryjne, 83, 285–288 (2008)
- Mahajan S., Rodgeres F.G.: Isolation, characterization, and host-cell-binding properties of a cytotoxin from Campylobacter jejuni. J. Clin. Microiol. 28, 1314–1320 (1990)
- Melo R.T., Mendonça E.P., Monteiro G.P., Siqueira M.C.: Intrinsic and extrinsic aspects on Campylobacter jejuni biofilms. Front. Microbiol. 8, 1–15 (2017)
- Miller C.E., Rock J.D., Ridley K.A., Williams P.H., Ketley J.M.: Utilization of lactoferrin-bound and transferrin-bound iron by Campylobacter jejuni. J. Bacteriol. 190, 1900–1911 (2008)
- Mohan V.: The role of probiotics inthe inhibition of Campylobacter jejuni colonization and virulence attenuation. Eur. J. Clin. Microbiol. Infect. Dis. 34, 1503–1513 (2015)
- Moran. A.P., Annuk H., Prendergast M.M.: Antibodies induced by ganglioside-mimicking Campylobacter jejuni lipooligosaccharides recognise epitopes at the nodes of Ranvier. J. Neuro-immunol. 165, 179–185 (2005)
- Nachamkin, I., Szymanski, M.C., Blaser, J.M.: Campylobacter. 3-cia ed.; ASM Press: Washington DC, USA (2008)
- Nothaft H., Szymański C.M. i wsp.: Engineering the Campylobacter jejuni N-glycan to create an effective chicken vaccine. Scientific Reports, 6, 26511 (2016)
- Nyati K.K., Nyati R.: Role of Campylobacter jejuni Infection in the Pathogenesis of Guillain-Barré Syndrome: An Update. Biomed. Res. Int. 852195 (2013)
- Nyati K.K., Prasad K.N.: Role of cytokines and Toll-Like receptors in the immunopathogenesis of Guillain-Barré syndrome. Mediators Inflamm. 758639, DOI:10.1155/2014/758639 (2014)
- Palyada K.,Threadgill D. and Stintzi A.: Iron acquisition and regulationin Campylobacter jejuni. J. Bacteriol. 186, 4714–4729 (2004)
- Phongsisay V.: The immunobiology of Campylobacter jejuni: innate immunity and autoimmune diseases. Immunobiol. 221, 535–543 (2015)
- Prendergastm M., Moran A.P.: Lipooligosaccharidies in the development of Guillain-Barre’s syndrome and Miller Fisher syndrome forms of acute inflammatory peripheral. Neuropathies J. Endotoxin Res. 6, 341–359 (2000)
- Ridley K.A., Rock J.D., Li Y., Ketley J.M.: Hem eutilizationin Campylobacter jejuni. J. Bacteriol. 188, 7862–7875 (2006)
- Rokosz-Chudziak N., Rastawicki W.: Wybrane mechanizmy chorobotwórczości pałeczek Campylobacter jejuni. Med. Dośw. Mikrobiol. 66, 47–58 (2014)
- Sait-Cyr M.J., Guyard-Nicodeme M., Messaoudi S., Chemaly M., Cappelier J.M., Dousset X., Haddad N.: Recent advanced in screening of anti-Campylobacter activity in priobiotics for use in poultry. Front. Microiol. 7, 1–22 (2016)
- Saxena A.: Probiotics as a potential alternative for relieving peripheral neurophaties: a case for Guillain-Barre’s syndrome. Front. Microbiol. 6, 1497 (2015)
- Shu X.M., Cai F.C., Zhang X.P.: Carbohydrate mimicry of Campylobacter jejuni lipooligosaccharide is critical for the induction of anti-GM1 antibody and neuropathy. Muscle Nerve, 33, 225–231 (2006)
- Silva J., Leite D., Fernandes M., Mena C., Gibbs P.A., Teixeira P.: Campylobacter spp. as a foodborne pathogen: a review. Front. Microbiol. 2, 200 (2011)
- Sofka D., Pfeifer A., Paulsen P., Hilbert F.: Changes with in the intestinal flora of broilers by colonisation with Campylobacter jejuni. Berl. Munch. Tierarztl.Wochenschr. 128, 104–110 (2015)
- Stahl M., Vallance B.A.: Insights into Campylobacter jejuni colonization of the mammalian intestinal tract using a novel mouse model of infection. Gut Microbe. 6, 143–148 (2015)
- Szymanski C.M. and Gaynor E.C.: How a sugary bug gets through the day. Recent developments in understanding fundamental processes impacting Campylobacter jejuni pathogenesis. Gut Microbe,3, 135–144 (2012)
- Wang Y., Sun S., Zhu J., Cui L., Zhang H.L.: Biomarkers of Guillain-Barre’s syndrome: Some recent progres, more still to be explored. Mediaors Inflamm. 5640098 (2015)
- Watson A.E., Sandu P., Gundogdu O., Mills D.C., Inglis N.F., Manson E., Imrie L., Bajaj-Elliott M., Wren B.W., Smith David G.E., Dorrella N.: Campylobacter jejuni outer membrane vesicles play an important role in bacterial interactions with human intestinal epithelial cells. Infect. Immun. 80, 4089–4098 (2012)
- Wieczorek K., Osek J. Antimicrobial resistance mechanisms among Campylobacter. Biomed. Res. Int. 340605, DOI: 10.1155/ 2013/340605 (2013)
- Xiang S.l., Zhong M., Cai F.C., Deng B., Zhang X.P.: The sialic acid residue i a crucial component of Campylobacter jejuni lipo-oligosaccharide ganglioside mimicry in the induction Guillain-Barre’s syndrome. J. Neuroimmunol. 174, 126–132 (2006)
- Xu F., Zeng X., Haigh R.D., Ketley J.M., Lin J.: Identification and characterization of a new ferric enterobactin receptor CfrB in Campylobacter. J. Bacteriol. 192, 4425–4435 (2010)
- Yu R.K., Usuki S., Ariga T. Ganglioside molecular mimicry and its pathological roles in Guillain-Barre’ syndrome and related diseases. Infect. Immun. 74, 6517–6527 (2006)
- Yuki N. Guillain-Barre syndrome and anti-ganglioside antibodies a clinician scientist’s journey. Proc. Jpn. Acad., Ser. B. Phys Biol. Sci. 88, 299–326 (2012)
- Yuki N.: Pathogenesis of Guillain-Barre and Miller Fisher syndromes subsequent to Campylobacter jejuni enteritis. Jpn. J. Infect. Dis. 2, 99–105 (1999)
- Yuki N, Hartung H.: Guillain-Barr’e Syndrome. New Engl. J. Med. 336, 294–304 (2012)
- Yuki N., Koga M.: Bacterial infections in Guillain-Barre and Fisher syndromes. Curr. Opin. Neurol. 19, 451–457 (1995)
- Yuki N., Odaka M.: Ganglioside mimicry as cause of Guillain-Barre’s syndrome. Curr. Opin. Neurol. 18, 557–561 (2005)
- Zang T., Dong J., Lu Q., Luo Q., Wen G., LiuG., Shao H.: Genotypic diversity, antymicrobial resistance and biofilm-forming abilities of Campylobacter isolated from chicken in Central China. Gut Pathogens, 9, 1–10 (2017)
- Zhang X.P., Gilbert M., Yuki N.,Cao F., Li J., Liu h., Lii Q., Meng F., Zhang J.: Association of anti GT1a antibodies with an outbreak of Guillain-Barre’s syndrome and analysis of gangliside mimicry in an associated Campylobacter jejuni strain. PLoS One,10, e0131730 (2015)